Adil Khan

Adil I. Khan MSc PhD is Professor of Professor of Pathology at the Lewis Katz School of Medicine, Temple University, in Philadelphia and the Medical Director for Point-of-Care Testing and Clinical Chemistry Laboratories for the Temple University Health System. He completed his MSc from the United Kingdom in Immunology of Infectious Diseases from at the London School of Hygiene & Tropical Medicine and his PhD in Immunology from the Hammersmith Hospital Campus of the National Heart & Lung Institute, Imperial College London. Dr. Khan then pursued a postdoctoral research fellowship at the University of Calgary, Canada studying the role of L-selectin and CD44 in models of acute inflammation, followed by a Postdoctoral Clinical Chemistry Training Fellowship at the University of Texas Southwestern Medical Center at Dallas. Professor Khan teaches pathology residents, medical students, and students of podiatric medicine and his research interests include understanding the role of adhesion molecules and extracellular vesicles in inflammation and recently, those associated with SAR-CoV-2. On the clinical side, as well as providing expert consultation to his colleagues, his interests include clinical trials of point-of-care testing devices /laboratory instruments, and assay development and identification of novel biomarkers of disease. He has numerous publications, co-authored various laboratory guidelines for the Clinical Laboratory Standards Institute, organized workshops and symposia. He is a member of the Canadian Society for Clinical Chemists and the Association for Diagnostics and Laboratory Medicine. He has also been the Treasurer and Chair of the Philadelphia section of the Association for Diagnostics and Laboratory Medicine and is currently the Chair of the International Federation of Clinical Chemistry and Laboratory Medicine Executive Board Committee on Point-of-Care Testing.